LuVaCs Leiden (@luvacsl) 's Twitter Profile
LuVaCs Leiden

@luvacsl

Lupus-, Vasculitis-, Complement mediated Systemic diseases (LuVaCs) Center of Expertise

ID: 1084169403976114176

linkhttps://www.lumc.nl/org/luvacs/ calendar_today12-01-2019 19:25:03

245 Tweet

394 Takipçi

409 Takip Edilen

LuVaCs Leiden (@luvacsl) 's Twitter Profile Photo

When science meets fashion...you get a revolution! No more sizes too small, too large, too narrow or too wide, repair of damage clothes...fashion, art and science all come together @ParisFashionWeek #Scienceismorethananopinion buff.ly/3RBeEvo buff.ly/3dZpqxT

When science meets fashion...you get a revolution! No more sizes too small, too large, too narrow or too wide, repair of damage clothes...fashion, art and science all come together @ParisFashionWeek #Scienceismorethananopinion

buff.ly/3RBeEvo 
buff.ly/3dZpqxT
Ahmed Marcouch (@ahmedmarcouch) 's Twitter Profile Photo

Ridder Menno Loos te Arnhem, van harte gefeliciteerd met de enorm eervolle onderscheiding tot Ridder in de Orde van Oranje-Nassau. Eerlijk verdiend, als initiatiefnemer tot de nieuwe wijze van donorregistratie.

Ridder Menno Loos te Arnhem, van harte gefeliciteerd met de enorm eervolle onderscheiding tot Ridder in de Orde van Oranje-Nassau. Eerlijk verdiend, als initiatiefnemer tot de nieuwe wijze van donorregistratie.
LuVaCs Leiden (@luvacsl) 's Twitter Profile Photo

Today we will present @SLEURO the results of the AURORA-2 study which investigated safety of 3-year long-term treatment with voclosporin versus placebo in #lupus nephritis patients...and obviously looked at prevention of kidney damage. Be there at 11AM CET buff.ly/3qJaKWj

Today we will present @SLEURO the results of the AURORA-2 study which investigated safety of 3-year long-term treatment with voclosporin versus placebo in #lupus nephritis patients...and obviously looked at prevention of kidney damage. Be there at 11AM CET
buff.ly/3qJaKWj
LuVaCs Leiden (@luvacsl) 's Twitter Profile Photo

By far the best way to end a very successful SLEuro lupus meeting i Stockholm.I hope to meet all international colleagues and friends soon again

By far the best way to end a very successful <a href="/SLEuroSociety/">SLEuro</a> lupus meeting i  Stockholm.I hope to meet all international colleagues and friends soon again
LuVaCs Leiden (@luvacsl) 's Twitter Profile Photo

Cyclophoshamide and Rituximab are successfully the standard of care for patients with active #ANCA-associated #vasculitis. Is combining both better? Read about our endevour to investigate this in the investigator-initiated randomized ENDURRANCE trial in buff.ly/3rqAWW7

Cyclophoshamide and Rituximab are successfully the standard of care for patients with active #ANCA-associated #vasculitis. Is combining both better?
Read about our endevour to investigate this in the investigator-initiated randomized ENDURRANCE trial in buff.ly/3rqAWW7
Andreas Kronbichler (@akronbichler) 's Twitter Profile Photo

What a great day at the EUVAS22 EUVAS meeting in Florence; Apart from technical issues (great view from the moderator perspective)! Moving words by Stephen McAdoo to honour Prof Justin Mason!

What a great day at the EUVAS22 <a href="/EUVAS19/">EUVAS</a> meeting in Florence; Apart from technical issues (great view from the moderator perspective)! Moving words by <a href="/stephenmcadoo/">Stephen McAdoo</a> to honour Prof Justin Mason!
Brad H Rovin (@bradrovin) 's Twitter Profile Photo

#IgANTreatment Great news for patients and docs. The data from the NefIgArd trial that led to accelerated approval of Nefecon for the treatment of IgAN just out in Kidney International on line. First of many new therapies for IgAN!🤞kidney-international.org/article/S0085-…

UNDERSTAND AAV (@understandaav) 's Twitter Profile Photo

With patient-friendly language and simplified science, the Dialogue Tool helps make all things AAV understandable for your patients, meaning they can get the best outcomes from appointments. Take a look today at: understandaav.com #AAV #ANCA #vasculitis #raredisease

EURORDIS-Rare Diseases Europe (@eurordis) 's Twitter Profile Photo

In February, the French Presidency held a Ministerial Conference where high-level representatives expressed their support for a European Action Plan on Rare Diseases. The upcoming Czech Expert Conference will define how this could be achieved. Read more: cutt.ly/HBJxIbK

Trinity Kidneys (@thkc1) 's Twitter Profile Photo

When you are a short arse and flanked by your tall _ERNRITA colleagues 😂 Wonderful celebration of the career of Carine Wouters in KU Leuven Research (proudly wearing my Imperial College London plumage).

When you are a short arse and flanked by your tall <a href="/_ERNRITA/">_ERNRITA</a> colleagues 😂

Wonderful celebration of the career of Carine Wouters in <a href="/leuvenresearch/">KU Leuven Research</a> (proudly wearing my <a href="/imperialcollege/">Imperial College London</a> plumage).
ASN Publications (@asnpublications) 's Twitter Profile Photo

Belimumab, a recombinant, human IgG1λ mAb, has been shown to improve kidney outcomes in patients with active lupus nephritis. This 28-week open-label extension of the BLISS-LN study assessed belimumab’s safety and efficacy bit.ly/CJN02520322 Brad H Rovin LUMC Leiden LuVaCs Leiden

Belimumab, a recombinant, human IgG1λ mAb, has been shown to improve kidney outcomes in patients with active lupus nephritis. This 28-week open-label extension of the BLISS-LN study assessed belimumab’s safety and efficacy bit.ly/CJN02520322

<a href="/BradRovin/">Brad H Rovin</a> <a href="/LUMC_Leiden/">LUMC Leiden</a> <a href="/LuvacsL/">LuVaCs Leiden</a>
Pankti Mehta (@panktimehta24) 's Twitter Profile Photo

📝A great compilation of newer treatment options for #Lupus Nephritis by a senior and friend! Sayali Thakare #SLE #RheumTwitter #MedTwitter #MedEd pubs.glomcon.org/lupus-nephriti…

📝A great compilation of newer treatment options for #Lupus Nephritis by a senior and friend! <a href="/SayaliBThakare/">Sayali Thakare</a> 

#SLE #RheumTwitter #MedTwitter #MedEd 

pubs.glomcon.org/lupus-nephriti…
burgerinitiatief 2MH - donorwet (@2miljoen) 's Twitter Profile Photo

❤️❤️❤️ het gaat GOED met #orgaandonatie in Nederland!! Wachtlijst neemt eindelijk af. Aantal donoren blijft ook dit jaar toenemen #donorwet > het aantal postmortale transplantaties daardoor neemt flink toe😀 & het # donaties bij leven ook📈#eurotransplant eurotransplant.org/statistics/mon…

❤️❤️❤️ het gaat GOED met #orgaandonatie in Nederland!!  Wachtlijst neemt eindelijk af. Aantal donoren blijft ook dit jaar toenemen #donorwet &gt; het aantal postmortale transplantaties daardoor neemt flink toe😀 &amp; het # donaties bij leven ook📈#eurotransplant eurotransplant.org/statistics/mon…
Peter Grayson (@petercgrayson) 's Twitter Profile Photo

They are finally out! 2022 ACR/EULAR Classification Criteria for Giant Cell Arteritis and Takayasu's Arteritis!!!! onlinelibrary.wiley.com/doi/10.1002/ar… onlinelibrary.wiley.com/doi/10.1002/ar…

LuVaCs Leiden (@luvacsl) 's Twitter Profile Photo

Reminds me of the way we teach our MDs and PhDs to care for patients with complex, systemic autoimmune diseases @LuvacsLeiden LUMC Leiden #nephrology #aav #lupus #complement #glomerulonephritis

burgerinitiatief 2MH - donorwet (@2miljoen) 's Twitter Profile Photo

❤️ het gaat echt #orgaandonatie. Dit jaar wordt het allerbeste ooit. Het kan niet anders dan dat de nieuwe #donorwet werkt 😊. Eurotransplant cijfers nov 2022 tov 2021 eurotransplant.org/statistics/mon…

❤️ het gaat echt #orgaandonatie. Dit jaar wordt het allerbeste ooit. Het kan niet anders dan dat de nieuwe #donorwet werkt 😊. <a href="/eurotransplant/">Eurotransplant</a> cijfers nov 2022 tov 2021 eurotransplant.org/statistics/mon…